Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
1997-08-14
Original market date: See footnote 1
1970-12-31
Product name:
ALUPENT LIQ 50MG/ML
DIN:
00003859 Electronic product monograph is not available
Company:
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
5180 South Service Road
Burlington
Ontario
Canada
L7L 5H4
Class:
Human
Dosage form(s):
Liquid
Route(s) of administration:
Oral , Inhalation
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
12:12.08.12
Anatomical Therapeutic Chemical (ATC): See footnote 4
R03AB03 ORCIPRENALINE
Active ingredient group (AIG) number:See footnote5
0102598003
Active ingredient(s) See footnote8 | Strength |
---|---|
ORCIPRENALINE SULFATE | 50 MG / ML |